Table 1.
Human and Nonhuman Cell Lines Used in the Present Study
| Organism, Anatomic Site, Cell Line | Abbreviation | Source |
|---|---|---|
| Human | ||
| Upper and lower respiratory tract | ||
| Laryngeal epidermoid carcinoma | Hep-2 | ATCC no. CCL-23 |
| Lung adenocarcinoma | A549 | ATCC no. CCL-185 |
| Lung adenocarcinoma | Calu-3 | ATCC no. HTB-55 |
| Embryonic lung fibroblasts | HFL | In-house development |
| Gastrointestinal tract | ||
| Colorectal adenocarcinoma | Caco-2 | ATCC no. HTB-37 |
| Liver | ||
| Hepatocellular carcinoma | Huh-7 | JCRB0403, JCRB cell bank of Okayama University |
| Genitourinary tract | ||
| Cervical adenocarcinoma | HeLa | ATCC no. CCL-2.2 |
| Fetal kidney | HEK | In-house development |
| Neuromuscular cells | ||
| Neuron-committed teratocarcinoma | NT2 | ATCC no. CRL-1973 |
| Rhabdomyosarcoma | RD | ATCC no. CCL-136 |
| Immune cells | ||
| Peripheral blood monocytes from acute monocytic leukemia | THP-1 | ATCC no. TIB-202 |
| Monocytes from histiocytic lymphoma | U937 | ATCC no. CRL-1593.2 |
| B lymphocytes from Burkitt lymphoma | Raji | ATCC no. CCL-86 |
| T lymphocytes from T-cell leukemia | H9 | ATCC no. HTB-176 |
| Malignant histiocytoma | His-1 | In-house development |
| Nonhuman | ||
| Mammals | ||
| Rhesus monkey kidney | LLC-MK2 | ATCC no. CCL-7 |
| African green monkey kidney | Vero | ATCC no. CCL-81 |
| African green monkey kidney (clone of Vero-76) | Vero-E6 | ATCC no. CRL-1586 |
| Madin-Darby canine kidney | MDCK | ATCC no. CCL-34 |
| Feline kidney | CRFK | ATCC no. CCL-94 |
| Porcine kidney | PK-15 | ATCC no. CCL-33 |
| Rabbit kidney | RK-13 | ATCC no. CCL-37 |
| Civet lung fibroblasts | CL-1 | In-house development |
| Primary mouse embryonic fibroblasts | 3T3 | ATCC no. CCL-92 |
| Rattus norvegicus kidney | RK3E | ATCC no. CRL-1895 |
| Rattus norvegicus kidney | RMC | ATCC no. CRL-2573 |
| Chicken | ||
| Chicken fibroblasts | DF-1 | ATCC no. CRL-12203 |
| Insect | ||
| Aedes albopictus | C6-36 | ATCC no. CRL-1660 |